ERASCA INC's ticker is and the CUSIP is 29479A108. A total of 112 filers reported holding ERASCA INC in Q2 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,064,422 | -37.8% | 540,316 | -12.9% | 0.00% | – |
| Q2 2023 | $1,711,563 | -80.9% | 620,132 | -79.2% | 0.00% | -100.0% |
| Q1 2023 | $8,959,316 | -22.5% | 2,976,517 | +11.0% | 0.00% | 0.0% |
| Q4 2022 | $11,560,869 | +1587.7% | 2,682,336 | +2957.6% | 0.00% | – |
| Q3 2022 | $685,000 | +687.4% | 87,727 | +466.0% | 0.00% | – |
| Q2 2022 | $87,000 | -27.5% | 15,499 | +11.7% | 0.00% | – |
| Q1 2022 | $120,000 | -19.5% | 13,874 | +44.9% | 0.00% | – |
| Q4 2021 | $149,000 | -40.2% | 9,574 | -18.3% | 0.00% | – |
| Q3 2021 | $249,000 | – | 11,725 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AH Equity Partners Bio II, L.L.C. | 2,500,000 | $19,500,000 | 13.59% |
| ARCH Venture Management, LLC | 11,055,554 | $86,233,000 | 11.18% |
| EDBI Pte Ltd | 888,888 | $6,933,000 | 7.30% |
| Cormorant Asset Management, LP | 10,505,554 | $81,943,000 | 5.73% |
| AH Equity Partners V, L.L.C. | 50,000 | $390,000 | 2.53% |
| AH Equity Partners LSV II, L.L.C. | 312,500 | $2,438,000 | 2.18% |
| PFM Health Sciences, LP | 7,264,981 | $56,667,000 | 2.05% |
| Artal Group S.A. | 3,172,221 | $24,743,000 | 1.06% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 472,472 | $3,685,000 | 0.75% |
| EcoR1 Capital, LLC | 678,441 | $5,292,000 | 0.16% |